0001787518 false 00000 Brilliant Acquisition Corp 00-0000000 China 0001787518 2021-10-13 2021-10-13 0001787518 BRLIU:UnitsEachConsistingOfOneOrdinaryShareOneRightAndOneRedeemableWarrantMember 2021-10-13 2021-10-13 0001787518 BRLIU:OrdinarySharesNoParValuePerShareMember 2021-10-13 2021-10-13 0001787518 BRLIU:RightsEachRightEntitlingHolderTo110OfOneOrdinaryShareMember 2021-10-13 2021-10-13 0001787518 BRLIU:WarrantsEachWarrantExercisableForOneOrdinaryShareFor11.50PerShareMember 2021-10-13 2021-10-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): October 13, 2021 

 

BRILLIANT ACQUISITION CORPORATION

(Exact name of registrant as specified in its charter)

 

British Virgin Islands   333-237153   N/A
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

99 Dan Ba Road, C-9, Putuo District,

Shanghai, Peoples Republic of China

(Address of principal executive offices, including zip code)

 

Registrant’s telephone number, including area code: (86) 021-80125497

 

Not Applicable
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
         
Units, each consisting of one Ordinary Share, one Right and one Redeemable Warrant   BRLIU   The Nasdaq Capital Market
         
Ordinary Shares, no par value per share   BRLI   The Nasdaq Capital Market
         
Rights, each right entitling the holder to 1/10 of one Ordinary Share   BRLIR   The Nasdaq Capital Market
         
Warrants, each warrant exercisable for one Ordinary Share for $11.50 per share   BRLIW   The Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

 

 

Item 8.01 Other Events.

 

As previously disclosed, on April 19, June 8 and August 31, 2021 respectively, the Company received three notices from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that, as a result of the Company’s failure to timely file its Annual Report on form 10-K for the fiscal year ended December 31, 2020 (the “Annual Report”), and its Quarterly Report on Form 10-Q for the period ended March 31, 2021 and for the period ended June 30, 2021 (the “Quarterly Reports”), the Company no longer complied with the continued listing requirements set forth in Nasdaq Listing Rule 5250(c)(1) (the “Rule”).

 

On October 12, 2021, the Company filed the relevant Annual Report and Quarterly Reports with the Securities and Exchange Commission, and on October 13, 2021, the Company received two letters (the “Compliance Letters”) from the Listing Qualifications Department of Nasdaq notifying the Company that upon reviewing the filed Annual Report and the Quarterly Report for the period ended March 31, 2021, Nasdaq determined that the Company now complies with the Rule. On October 18, 2021, the Company received an additional letter (the “Additional Compliance Letter”) from the Listing Qualifications Department of Nasdaq, notifying the Company that upon reviewing the filed Quarterly Report for the period ended June 30, 2021, Nasdaq determined the Company now complies with the Rule. Nasdaq additionally noted that the matters are now closed.

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  BRILLIANT ACQUISITION CORPORATION
     
  By:   /s/ Dr. Peng Jiang
    Name:  Dr. Peng Jiang
    Title: Chief Executive Officer
     
Dated: October 18, 2021